Document Type : Original Article


1 Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Department of Physiology, Faculty of Medicine, Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

3 Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

4 Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran


Studies conducted on animal models have shown that the administration of glycerol can lead to kidney tissue damage and impaired renal function. This is believed to be caused by oxidative stress and inflammation, which in turn can result in elevated levels of blood urea nitrogen (BUN) and creatinine. These metabolites are commonly used as indicators of renal function. The aim of the current experimental research was to investigate the protective efficacy of ellagic acid in a rat model of rhabdomyolysis induced by glycerol. Sixty healthy adult male Wistar rats weighing between 250 - 300 g were divided into five equal groups including control, rhabdomyolysis (administered 8.00 mL kg-1 of glycerol), and three rhabdomyolysis plus various doses of ellagic acid (25.00, 50.00 and 100 mg kg-1 per day; 72 hr after receiving glycerol for 14 days successively) groups. Serum levels of BUN, creatinine, lactate dehydrogenase, alkaline phosphatase, electrolytes and inflammatory cytokines were evaluated in all rats. Histopathological studies were also performed on kidney tissues from all groups. The administration of ellagic acid resulted in a significant increase in renal function biomarkers compared to the rats with acute kidney injury. This increase was consistent with notable reductions in tumor necrosis factor-α levels and increases in interleukin-10 levels observed in blood samples. Furthermore, the improvement in histopathological indices observed in rats received ellagic acid confirmed its nephroprotective role. The results of the current experimental study suggest that ellagic acid can improve kidney damage following glycerol injection, potentially by modulating the inflammatory process.


Main Subjects

  1. Gu H, Yang M, Zhao X, et al. Pretreatment with hydrogen-rich saline reduces the damage caused by glycerol-induced rhabdomyolysis and acute kidney injury in rats. J Surg Res 2014; 188(1): 243-249.
  2. Okubo K, Kurosawa M, Kamiya M, et al. Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury. Nat Med 2018; 24(2): 232-238.
  3. Al-Jaghbeer M, Dealmeida D, Bilderback A, et al. Clinical decision support for in-hospital AKI. J Am Soc Nephrol 2018; 29(2): 654-660.
  4. Wonnacott A, Meran S, Amphlett B, et al. Epidemiology and outcomes in community-acquired versus hospital-acquired AKI. Clin J Am Soc Nephrol 2014; 9(6): 1007-1014.
  5. Mesropian PD, Othersen J, Mason D, et al. Community-acquired acute kidney injury: a challenge and opportunity for primary care in kidney health. Nephrology (Carlton) 2016; 21(9): 729-235.
  6. Turgut F, Awad AS, Abdel-Rahman EM. Acute kidney injury: medical causes and pathogenesis. J Clin Med 2023; 12(1): 375. doi: 10.3390/jcm12010375.
  7. Hanna J, Hossain GS, Kocerha J. The potential for microRNA therapeutics and clinical research. Front Genet 2019; 10: 478. doi: 10.3389/fgene.2019.00478.
  8. Boada-Romero E, Martinez J, Heckmann BL, et al. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol 2020; 21(7): 398-414.
  9. Boutaud O, Roberts LJ 2nd. Mechanism-based thera-peutic approaches to rhabdomyolysis-induced renal failure. Free Radic Biol Med 2011; 51(5): 1062-1067.
  10. Reeder BJ, Sharpe MA, Kay AD, et al. Toxicity of myoglobin and hemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid hemorrhage. Biochem Soc Trans 2002; 30(4): 745-748.
  11. Moore KP, Holt SG, Patel RP, et al. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 1998; 273(48): 31731-31737.
  12. Liu M, Liang Y, Chigurupati S, et al. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol 2008; 19(7): 1360-1370.
  13. Wu J, Pan X, Fu H, et al. Effect of curcumin on glycerol-induced acute kidney injury in rats. Sci Rep 2017; 7(1): 10114. doi: 10.1038/s41598-017-10693-4.
  14. Chander V, Singh D, Chopra K. Catechin, a natural antioxidant protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Pharmacol Res 2003; 48(5): 503-509.
  15. Al Asmari AK, Al Sadoon KT, Obaid AA, et al. Protective effect of quinacrine against glycerol-induced acute kidney injury in rats. BMC Nephrol 2017; 18(1): 41. doi: 10.1186/s12882-017-0450-8.
  16. Song SJ, Kim SM, Lee SH, et al. Rhabdomyolysis-induced AKI was ameliorated in NLRP3 KO mice via alleviation of mitochondrial lipid peroxidation in renal tubular cells. Int J Mol Sci 2020; 21(22): 8564. doi: 10.3390/ijms21228564.
  17. Zurovsky Y. Models of glycerol-induced acute renal failure in rats. J Basic Clin Physiol Pharmacol 1993; 4(3): 213-228.
  18. Mohammed ET, Hashem KS, Abdelazem AZ, et al. Prospective protective effect of Ellagic acid as a SIRT1 activator in iron oxide nanoparticle-induced renal damage in rats. Biol Trace Elem Res 2020; 198(1): 177-188.
  19. Chen S, Zhou M, Ying X, et al. Ellagic acid protects rats from chronic renal failure via MiR-182/FOXO3a axis. Mol Immunol 2021; 138: 150-160.
  20. Aslan A, Gok O, Beyaz S, et al. Ellagic acid prevents kidney injury and oxidative damage via regulation of Nrf-2/NF-κB signaling in carbon tetrachloride induced rats. Mol Biol Rep 2020; 47(10): 7959-7970.
  21. Mehrzadi S, Fatemi I, Malayeri AR, et al. Ellagic acid mitigates sodium arsenite-induced renal and hepatic toxicity in male Wistar rats. Pharmacol Rep 2018; 70(4): 712-719.
  22. Aslan A, Beyaz S, Gok O, et al. The effect of ellagic acid on caspase-3/bcl-2/Nrf-2/NF-kB/TNF-α/COX-2 gene expression product apoptosis pathway: a new approach for muscle damage therapy. Mol Biol Rep 2020; 47(7): 2573-2582.
  23. Moore PK, Hsu RK, Liu KD. Management of acute kidney injury: core curriculum 2018. Am J Kidney Dis 2018; 72(1): 136-148.
  24. Li YF, Xu BY, An R, et al. Protective effect of anisodamine in rats with glycerol-induced acute kidney injury. BMC Nephrol 2019; 20(1): 223. doi: 10.1186/s12882-019-1394-y.
  25. Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care 2014; 18(3): 224. doi: 10.1186/cc13897.
  26. Sharawy MH, Abdelrahman RS, El-Kashef DH. Agmatine attenuates rhabdomyolysis-induced acute kidney injury in rats in a dose dependent manner. Life Sci 2018; 208: 79-86.
  27. Choghakabodi PM, Pouladzadeh M, Haybar H, et al. Biological whistleblowers for silent myocardial ischemia: diagnostic and prognostic approach. Recent Prog Med 2020; 111(7): 415-425.
  28. Rapa SF, Di Iorio BR, Campiglia P, et al. Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci 2019; 21(1): 263. doi: 10.3390/ijms21010263.
  29. de Souza SI, Rocha EC, Ferraz HR, et al. Acute kidney injury induced by glycerol is worsened by orchiectomy and attenuated by testosterone replacement. Steroids 2021; 165: 108755. doi: 10.1016/j.steroids. 2020.108755.
  30. Park CH, Tanaka T, Cho EJ, et al. Glycerol-induced renal damage improved by 7-O-galloyl-D-sedoheptulose treatment through attenuating oxidative stress. Biol Pharm Bull 2012; 35(1): 34-41.
  31. Karam H, Bruneval P, Clozel JP, et al. Role of endothelin in acute renal failure due to rhabdomyolysis in rats. J Pharmacol Exp Ther 1995; 274(1): 481-486.
  32. Al Laham SA. The curative effects of methyl-sulfonylmethane against glycerol-induced acute renal failure in rats. Braz J Pharm Sci 2018; 54(01): e17442. doi: 10.1590/s2175-97902018000117442
  33. Ahad A, Ganai AA, Mujeeb M, et al. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy. Chem Biol Interact 2014; 219: 64-75.
  34. Reis NG, Francescato HD, de Almeida LF, et al. Protective effect of calcitriol on rhabdomyolysis-induced acute kidney injury in rats. Sci Rep 2019; 9(1): 7090. doi: 10.1038/s41598-019-43564-1
  35. Mirzaie Z, Bastani A, Haji-Aghamohammadi AA, et al. Effects of ellagic acid on oxidative stress index, inflammatory markers and quality of life in patients with irritable bowel syndrome: randomized double-blind clinical trial. Clin Nutr Res 2022; 11(2): 98-109.
  36. Rosillo MA, Sanchez-Hidalgo M, Cárdeno A, et al. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem Pharmacol 2011; 82(7): 737-745.
  37. Craig WJ. Phytochemicals: guardians of our health. J Am Diet Assoc 1997; 97(10 Suppl 2): S199-S204.